non-glp-1 medications Obesity care isn't one-drug-fits-all. ​ Obesity management is evolving beyond GLP-1 medications. ​ This session explores personalized approaches that improve outcomes across diverse patient populations. ​ Learn how non- GLP-1 therapies can support The Impact of GLP-1 Receptor

Urine albumin testing may be appropriate for people with diabetes or kidney risk

Is it safe for children or older adults

GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped

Potential Reasons to Consider Saxenda Insurance considerations: Your insurance covers Saxenda but not semaglutide Prior authorization requirements differ Step therapy requires trying Saxenda first Previous experience: Youve had success with Saxenda before You know you tolerate liraglutide well Youre continuing existing treatment Specific medical situations: Your provider has specific reasons to prefer liraglutide You have conditions that favor one medication over the other Part of a comprehensive treatment plan designed around liraglutide Personal preference: You strongly prefer daily dosing (some patients find this easier to remember) You want the FDA-approved weight loss indication specifically When Semaglutide Is Almost Always Better For most patients, semaglutide is preferable: Greater effectiveness: Nearly twice the weight loss makes a substantial difference in outcomes

A clinician can confirm the presence of gallstones with an imaging test

Culinary medicine and culinary nutrition education for individuals with the capacity to influence health related behaviour change: a scoping review